Double Point Ventures

Double Point Ventures is a venture capital firm that invests in early-stage healthcare companies, focusing on transformative innovations in therapeutics and digital health. The firm strategically backs ventures at critical inflection points, aiming to scale novel technologies and address significant market needs. They guide these companies to develop and implement impactful solutions within the evolving healthcare landscape.

Established in 2023, Double Point Ventures was founded by Campbell Murray, MD, MPP, MBA, and Daniel Yadegar, MD, who serve as co-founders and managing partners. Dr. Murray contributes a strong background in life sciences and breakthrough technologies, including co-founding Synchron. Dr. Yadegar brings a medical and strategic perspective to the firm's investment thesis, underpinning their approach to healthcare innovation.

Double Point Ventures primarily supports early-stage healthcare companies seeking capital and strategic guidance. The firm’s vision centers on empowering visionary founders developing advanced solutions, spanning gene therapies and precision medicines, designed to enhance patient outcomes. Their objective is to foster scalable solutions that fundamentally transform healthcare delivery.